Incannex Healthcare Inc. (IXHL)
IXHL moved a median of -0.71% 30 minutes after news, and -1.33% by the close. How IXHL actually reacts to news — the realized, point-in-time move the market made, measured across 231 labeled events over the last three years with zero look-ahead.
IXHL’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 45% | 221 |
| 30-min | -0.71% | 38% | 225 |
| 60-min | -0.34% | 47% | 228 |
| to close | -1.33% | 44% | 229 |
| Middle 50% of IXHL reactions | -4.14% to +1.63% |
|---|---|
| Median reaction (30-min) | -0.71% |
| Measured reactions | 231 |
Half of all Incannex Healthcare Inc. news events land between -4.14% and +1.63% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when IXHL moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to IXHL's baseline. Nothing else.
Recent IXHL events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-K Incannex Healthcare Inc. For: Jun 30 | SEC filing · Form 10-K | SEC EDGAR | -0.17% | -1.77% | |
| Form 8-K Incannex Healthcare Inc. For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | +0.60% | -2.42% | |
| Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position | Press release | GlobeNewswire | +0.60% | -2.42% | |
| Form 8-K Incannex Healthcare Inc. For: Aug 25 | SEC filing · Form 8-K | SEC EDGAR | +2.77% | +3.88% | |
| Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X | Press release | GlobeNewswire | +2.77% | +3.88% | |
| Form 8-K Incannex Healthcare Inc. For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | -1.51% | -3.03% | |
| Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026 | Press release | GlobeNewswire | -1.51% | -3.03% | |
| Form 8-K Incannex Healthcare Inc. For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.61% | |
| Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea | Press release | GlobeNewswire | +0.00% | +1.61% | |
| Form 8-K Incannex Healthcare Inc. For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | +2.98% | -3.90% | |
| Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea | Press release | GlobeNewswire | +2.98% | -3.90% | |
| Form 8-K Incannex Healthcare Inc. For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | +2.47% | +6.25% | |
| Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility | Press release | GlobeNewswire | +2.47% | +6.25% | |
| Form 8-K Incannex Healthcare Inc. For: Jun 09 | SEC filing · Form 8-K | SEC EDGAR | +5.25% | +7.00% | |
| Incannex Announces Initiation of Research Coverage by Alliance Global Partners | Press release | GlobeNewswire | +5.25% | +7.00% | |
| Form 10-Q Incannex Healthcare Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +3.30% | +2.86% | |
| Form 8-K Incannex Healthcare Inc. For: May 14 | SEC filing · Form 8-K | SEC EDGAR | +0.78% | +0.78% | |
| Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea | Press release | GlobeNewswire | -0.26% | -0.77% | |
| Form 8-K Incannex Healthcare Inc. For: May 12 | SEC filing · Form 8-K | SEC EDGAR | -1.83% | -10.55% | |
| Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development | Press release | GlobeNewswire | -1.83% | -10.55% | |
| Form 8-K Incannex Healthcare Inc. For: Apr 22 | SEC filing · Form 8-K | SEC EDGAR | +0.25% | +8.20% | |
| Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness | Press release | GlobeNewswire | +0.25% | +8.20% | |
| Form 8-K Incannex Healthcare Inc. For: Mar 27 | SEC filing · Form 8-K | SEC EDGAR | +4.31% | -6.90% | |
| Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position | Press release | GlobeNewswire | +4.31% | -6.90% | |
| Form 8-K Incannex Healthcare Inc. For: Mar 25 | SEC filing · Form 8-K | SEC EDGAR | +1.79% | +15.00% | |
| Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research | Press release | GlobeNewswire | +1.79% | +15.00% | |
| Form 8-K Incannex Healthcare Inc. For: Mar 18 | SEC filing · Form 8-K | SEC EDGAR | -1.82% | -6.36% | |
| Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development | Press release | GlobeNewswire | -1.82% | -6.36% | |
| Form 8-K Incannex Healthcare Inc. For: Mar 16 | SEC filing · Form 8-K | SEC EDGAR | +2.73% | +0.30% | |
| Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement | Press release | GlobeNewswire | +2.73% | +0.30% | |
| Form 8-K Incannex Healthcare Inc. For: Mar 11 | SEC filing · Form 8-K | SEC EDGAR | +7.52% | -22.81% | |
| Form 8-K Incannex Healthcare Inc. For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | +7.52% | -22.81% | |
| Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | Press release | GlobeNewswire | +7.52% | -22.81% | |
| Incannex Strengthens Clinical Development Pathway for IHL-42X Following Positive Phase 2 Outcomes | Press release | GlobeNewswire | +7.52% | -22.81% | |
| Form 8-K Incannex Healthcare Inc. For: Feb 24 | SEC filing · Form 8-K | SEC EDGAR | +8.33% | -11.89% | |
| Incannex Announces Reverse Stock Split | Press release | GlobeNewswire | +8.33% | -11.89% | |
| Form 10-Q Incannex Healthcare Inc. For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.86% | -2.04% | |
| Form 8-K Incannex Healthcare Inc. For: Jan 29 | SEC filing · Form 8-K | SEC EDGAR | +1.21% | -1.11% | |
| Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board | Press release | GlobeNewswire | +1.21% | -1.11% | |
| Form 8-K Incannex Healthcare Inc. For: Jan 22 | SEC filing · Form 8-K | SEC EDGAR | +1.76% | -1.35% | |
| Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program | Press release | GlobeNewswire | +1.76% | -1.35% | |
| Form 8-K Incannex Healthcare Inc. For: Jan 15 | SEC filing · Form 8-K | SEC EDGAR | -0.55% | -1.87% | |
| Form 8-K Incannex Healthcare Inc. For: Jan 15 | SEC filing · Form 8-K | SEC EDGAR | -1.50% | -9.05% | |
| Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards | Press release | GlobeNewswire | -1.50% | -9.05% | |
| Form 8-K Incannex Healthcare Inc. For: Jan 14 | SEC filing · Form 8-K | SEC EDGAR | -1.30% | +1.49% | |
| Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026 | Press release | GlobeNewswire | -1.30% | +1.49% | |
| Form 8-K Incannex Healthcare Inc. For: Dec 18 | SEC filing · Form 8-K | SEC EDGAR | +3.51% | -3.15% | |
| Form DEFA14A Incannex Healthcare Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +3.51% | -3.15% | |
| Form DEFA14A Incannex Healthcare Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +1.30% | +12.96% | |
| Form 8-K Incannex Healthcare Inc. For: Dec 03 | SEC filing · Form 8-K | SEC EDGAR | -7.75% | -6.90% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the IXHL section they belong to.
Where else IXHL is measured.
IXHL earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Incannex Healthcare Inc.'s median reaction calculated?
Every labeled IXHL news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 231 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 38% of IXHL's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does IXHL's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.